There should be a prohibition on this. I’m serious. Companies should not be allowed to talk about their products’s presumed efficacy or safety before data has been released.
Consider that so many products have been overpromised and underdelivered throughout this pandemic. Yes, folks, this includes the wonderful vaccines, which I wholeheartedly defend, but are NOT what the CEOs of these companies promised us.
Here’s a list of some of the overpromised and underdelivered drugs and vaccines:
– Remdesivir
– All the vaccines
– Paxlovid
– Merck’s Covid treatment molnupiravir
You could add face masks to your list as well.
Inconsistent messaging on face masks by public health officials, yes. But, my point here was to criticize company chiefs – ones who stand to earn tons of money if their products get chosen over others – for spinning narratives PRIOR to data being released. It’s so darn unethical.
With face masks, it’s not about a conflict of interest. With vaccines and treatments it is. Note, I’m not against vaccines or treatments. But, the press releases and statements by ALL CEOs of these companies have been much, much too rosy. I’ve said this from day one. I’ve never trusted a press release from any company at any time in the pandemic. The statements made by CEOs have been even worse. Bourla has advocated boosters and treatments prior to the FDA even getting a chance to review the data. Sorry, that’s criminal, in my view.
Especially in light of the fragmented reporting of cases and narrowing of Covid hospitalizations, the significant increases in both are concerning (they would be higher with better reporting). I would have expected a plateau or downturn nationwide by now (May). Still not a massive surge, which is good. But, the virus is clearly around in abundance and doing damage. It’s a steady drip – like today’s death tally in Massachusetts of 14. Not a lot compared to the bad days, but 14 is much higher than a day, say, in mid winter when we’re experiencing a severe flu outbreak. https://twitter.com/EricTopol/status/1522009851123040256
C-19
5-5
ready
Comments are closed.
Your no-hype southeastern New England weather blog!
Am I the only person who finds this annoying? CEOs of companies speaking to the media about their products BEFORE data has even been released? https://twitter.com/megtirrell/status/1521555526877949955
There should be a prohibition on this. I’m serious. Companies should not be allowed to talk about their products’s presumed efficacy or safety before data has been released.
Consider that so many products have been overpromised and underdelivered throughout this pandemic. Yes, folks, this includes the wonderful vaccines, which I wholeheartedly defend, but are NOT what the CEOs of these companies promised us.
Here’s a list of some of the overpromised and underdelivered drugs and vaccines:
– Remdesivir
– All the vaccines
– Paxlovid
– Merck’s Covid treatment molnupiravir
You could add face masks to your list as well.
Inconsistent messaging on face masks by public health officials, yes. But, my point here was to criticize company chiefs – ones who stand to earn tons of money if their products get chosen over others – for spinning narratives PRIOR to data being released. It’s so darn unethical.
With face masks, it’s not about a conflict of interest. With vaccines and treatments it is. Note, I’m not against vaccines or treatments. But, the press releases and statements by ALL CEOs of these companies have been much, much too rosy. I’ve said this from day one. I’ve never trusted a press release from any company at any time in the pandemic. The statements made by CEOs have been even worse. Bourla has advocated boosters and treatments prior to the FDA even getting a chance to review the data. Sorry, that’s criminal, in my view.
Thanks TK.
Familiar theme in my latest article: While the business of healthcare is booming, health outcomes falter. Not a good combination. https://www.forbes.com/sites/joshuacohen/2022/05/04/fda-commissioner-califf-says-business-of-health-is-booming-in-us-but-patients-outcomes-arent-improving/?sh=7d9310715edc
Pfizer CEO Bourla again – this time on Paxlovid – with conflict of interest “recommendations,” which the FDA has had to refute! I can’t stand this guy. He just sees dollar signs everywhere. There has to be a way to muzzle this. CEOs should NOT be allowed to do this. It’s egregiously unethical. https://endpts.com/despite-albert-bourlas-comments-fda-tells-doctors-not-to-re-treat-with-paxlovid-if-symptoms-return/
Especially in light of the fragmented reporting of cases and narrowing of Covid hospitalizations, the significant increases in both are concerning (they would be higher with better reporting). I would have expected a plateau or downturn nationwide by now (May). Still not a massive surge, which is good. But, the virus is clearly around in abundance and doing damage. It’s a steady drip – like today’s death tally in Massachusetts of 14. Not a lot compared to the bad days, but 14 is much higher than a day, say, in mid winter when we’re experiencing a severe flu outbreak. https://twitter.com/EricTopol/status/1522009851123040256
C-19
5-5
ready